Pharma News
Study Urges Enhanced Academia-Industry Collaboration at NIPERs to Foster Self-Reliance A recent study conducted by the Entrepreneurship Development Institute of […]
Sobi Begins FDA Submission Process for SEL-212, Advancing Potential Treatment for Chronic Refractory Gout Sobi has commenced a rolling Biologics
Centralized Guidelines for Export No Objection Certificates (NOCs): A Paradigm Shift in Drug Manufacturing Regulations In a significant regulatory overhaul,
Telangana Emerges as a Prime Destination for Pharma Investment, Attracting Leading Companies Telangana’s strategic initiatives in fostering innovation, manufacturing excellence,
The Indian Pharmacopoeia Commission – Materiovigilance Programme of India (IPC-MvPI) has been provisionally approved by the Quality Council of India
Quest Diagnostics, a prominent provider of diagnostic information services, has entered into a definitive agreement with OMERS to acquire LifeLabs,
Hutchmed (China) Limited has announced a significant development in the regulatory pathway of tazemetostat for the treatment of adult patients
Johnson & Johnson Reports Significant Survival Benefit in Phase 3 Study of Carvykti for Multiple Myeloma Johnson & Johnson has
Boehringer Ingelheim and Gubra Launch Phase 1 Study of BI 3034701, a Promising Triple Agonist Peptide for Obesity Treatment Boehringer
AstraZeneca’s application for sipavibart has been accepted by the European Medicines Agency (EMA) through an accelerated assessment procedure. This application